摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,1'-m-xylylbis(1,4,8,11-tetraazacyclotetradecane) | 110078-44-9

中文名称
——
中文别名
——
英文名称
1,1'-m-xylylbis(1,4,8,11-tetraazacyclotetradecane)
英文别名
1-[3-(1,4,8,11-tetraazacyclotetradecan-1-ylmethyl)benzyl]-1,4,8,11-tetraazacyclotetradecane;N,N'-m-xylenebis(tetraazacyclam);1,1'-[ 1,3-phenylenebis(methylene)]-bis-1,4,8,11-tetra-azacyclotetradecane;1,1'-[1,3-phenylene-bis(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane;1,1'-[1,3-phenylenebis(methylene)]-bis-1,4,8,11-tetra-azacyclotetradecane;1,1'-[1,3-phenylenebis(methylene)}-bis-1,4,8,11-tetra-azacyclotetradecane;1-[[3-(1,4,8,11-Tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane
1,1'-m-xylylbis(1,4,8,11-tetraazacyclotetradecane)化学式
CAS
110078-44-9
化学式
C28H54N8
mdl
——
分子量
502.79
InChiKey
TWROELGOZKDRSL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    656.6±55.0 °C(Predicted)
  • 密度:
    0.962±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    36
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.79
  • 拓扑面积:
    78.7
  • 氢给体数:
    6
  • 氢受体数:
    8

安全信息

  • 海关编码:
    2933990090

SDS

SDS:11b66e4ea9b6b6af89a1cd5a8c677de9
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Linked cyclic polyamines with activity against hiv.
    申请人:AnorMED Inc.
    公开号:EP1223166A1
    公开(公告)日:2002-07-17
    There is disclosed a pharmaceutical composition comprising as active ingredient a linked cyclic compound of general formula I,         Z - R - A - R' - Y     (I) in which Z and Y are independently cyclic polyamine moieties having from 9 to 32 ring members and from 3 to 8 amine nitrogens in the ring spaced by 2 or more carbon atoms from each other,    A is an aromatic or heteroaromatic moiety,    R and R' are each a substituted or unsubstituted alkylene chain or heteroatom containing chain. or an acid addition salt or metal complex thereof, in admixture or association with a pharmaceutically acceptable diluent or carrier.
    揭示了一种药物组合物,其包含一种作为活性成分的一般式I的环链化合物,其中Z和Y分别是具有9至32个环成员和3至8个胺氮的环状多胺基团,这些胺氮在环中相距至少2个或更多个碳原子,A是芳香或杂芳基团,R和R'分别是取代或未取代的烷基链或含有杂原子的链,或其酸盐或金属络合物,与药用可接受的稀释剂或载体混合或结合。
  • Mono N-functionalization of cyclic and linear tetraamines via their tridentate tricarbonylchromium complexes
    作者:Jean-Jacques Yaouanc、Nathalie Le Bris、Guénaëlle Le Gall、Jean-Claude Clément、Henri Handel、Hervé des Abbayes
    DOI:10.1039/c39910000206
    日期:——
    11-tetraazacyclotetradecane 2, 1,4,7,10-tetraazadecane 3 and 1,5,8,12-tetraazadodecane 4 have been selectively alkylated in high yield at the uncomplexed nitrogen atom, giving rise to mono N-functionalized tetraamines and bis-macrocyclic compounds.
    的FAC -LCR(CO)3个1,4,7,10-四的三齿配合物1,1,4,8,11-四氮杂2,1,4,7,10- tetraazadecane 3和1,5,8,已在未络合的氮原子上高产率地选择性地烷基化了十二-十四氮十二烷4,产生了单N-官能化的四胺和双大环化合物。
  • Trivalent protecting groups for the synthesis of symmetrical and unsymmetrical bis-tetraazamacrocycles
    作者:I. Gardinier、A. Roignant、N. Oget、H. Bernard、J.J. Yaouanc、H. Handel
    DOI:10.1016/0040-4039(96)01722-4
    日期:1996.10
    bis-tetraazamacrocycles are reported starting from tripotection of tetraazamacrocycles. The triprotected macrocycle was mono N-alkylated and then this compound reacted with another macrocycle to give symmetrical or unsymmetrical bis-tetraazamacrocycles.
    据报道,双-四氮杂大环化合物的合成很容易,是从四氮杂大环化合物的三鼎化开始的。三被保护的大环被单N-烷基化,然后该化合物与另一个大环反应以产生对称或不对称的双-四氮杂大环。
  • Chemokine combinations to mobilize progenitor/stem cells
    申请人:Bridger J. Gary
    公开号:US20060035829A1
    公开(公告)日:2006-02-16
    Methods to elevate progenitor and stem cell counts in animal subjects using compounds which bind to the chemokine receptor CXCR4 in combination with the CXCR2 chemokine GROβ, including its modified forms, are disclosed.
    使用与趋化因子受体CXCR4结合的化合物与CXCR2趋化因子GROβ及其改良形式结合,揭示了提高动物主体中祖细胞和干细胞数量的方法。
  • Methods to mobilize progenitor/stem cells
    申请人:——
    公开号:US20030130250A1
    公开(公告)日:2003-07-10
    Methods to elevate progenitor and stem cell counts in animal subjects using compounds which bind to the chemokine receptor CXCR4 are disclosed. Preferred embodiments of such compounds are of the formula Z-linker-Z′  (1) or pharmaceutically acceptable salt thereof wherein Z is a cyclic polyamine containing 9-32 ring members of which 3-8 are nitrogen atoms, said nitrogen atoms separated from each other by at least 2 carbon atoms, and wherein said heterocycle may optionally contain additional heteroatoms besides nitrogen and/or may be fused to an additional ring system; or Z is of the formula 1 wherein A comprises a monocyclic or bicyclic fused ring system containing at least one N and B is H or an organic moiety of 1-20 atoms, Z′ may be embodied in a form as defined by Z above, or alternatively may be of the formula —N(R)—(CR 2 ) n —X wherein each R is independently H or straight, branched or cyclic alkyl (1-6C), n is 1 or 2, and X is an aromatic ring, including heteroaromatic rings, or is a mercaptan; “linker” represents a bond, alkylene (1-6C) or may comprise aryl, fused aryl, oxygen atoms contained in an alkylene chain, or may contain keto groups or nitrogen or sulfur atoms.
    公开了一种使用与趋化因子受体CXCR4结合的化合物来提高动物主体和干细胞数量的方法。这些化合物的首选实施例为以下公式所示:Z-连接物-Z′(1)或其药用盐,其中Z是含有9-32个环成员的环状多胺,其中3-8个是氮原子,所述氮原子彼此之间至少相隔2个碳原子,且所述杂环除了氮原子外还可以包含额外的杂原子和/或与额外的环系统融合;或者Z为以下公式1所示:其中A包括至少一个N的单环或双环融合环系统,B为H或1-20个原子的有机基团,Z'可以采用如上所定义的Z的形式,或者也可以是以下公式的形式:-N(R)-(CR2)n-X其中每个R独立地为H或直链、支链或环烷基(1-6C),n为1或2,X为芳香环,包括杂芳环,或者是硫醇;“连接物”代表键,烷基(1-6C)或可能包含芳基、融合芳基、含在烷基链中的氧原子,或者可能含有酮基团、氮原子或硫原子。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐